OCRA has awarded 400 grants and invested $137 million in ovarian cancer and related gynecologic cancer research initiatives, becoming the largest global charity devoted to ovarian and related gynecologic cancer research in the world.
OCRA has awarded 400 grants and invested $137 million in ovarian cancer and related gynecologic cancer research initiatives, becoming the largest global charity devoted to ovarian and related gynecologic cancer research in the world.
Our commitment to cutting-edge research has resulted in scientific breakthroughs that are igniting hope worldwide and galvanizing top researchers as never before.
OCRA is proud to support groundbreaking ovarian cancer and related gynecologic cancer research. With an annual grantmaking budget of over $7 million, we fund scientists at all stages of their careers. OCRA-funded scientists are working in areas ranging from AI and basic science to clinical and translational research. They are also exploring disease at the cellular and molecular level.
Our researchers come from across the country and around the globe. While their areas of research may differ, they are united in their passion to find a cure and their desire to collaborate and innovate to improve the lives of patients.
OCRA’s new research partnership, The Edmée Firth Fund for Research in Ovarian Cancer (EFFROC), is funding research to develop clinical testing methods and education to increase physicians’ awareness of the disease and the importance of early detection. It is also funding research into ways to reduce the toxicity and side effects of second-line treatments and to improve targeted therapies.
KVIA-TV ABC-7 News El Paso recently spotlighted the groundbreaking work of OCRA-funded researcher Daniel Heller, PhD of Memorial Sloan Kettering Cancer Center, whose research lab is working to develop a … Continued
Scientists have identified sixteen potential therapeutic targets in low-grade serous ovarian cancer by studying proteins at the molecular level, with results published on August 11, 2025, in the journal Cancer … Continued
This article was updated in May 2025 to reflect NCCN’s release of the 2025 Guidelines for Cervical Cancer Patients. OCRA is a proud sponsor of 2025 Cervical Cancer Updates. We … Continued
Get email updates about research news, action alerts, and ways to join the fight.
